Literature DB >> 26226895

The medicinal properties and phytochemistry of plants of the genus Terminalia (Combretaceae).

I E Cock1,2.   

Abstract

Plants of the genus Terminalia are amongst the most widely used plants for traditional medicinal purposes worldwide. Many species are used for their antibacterial, antifungal, antiprotozoal, antiviral, antidiarrhoeal, analgesic, antimalarial, antioxidant, antiinflammatory and anticancer activities. Wound healing and cardiovascular effects have also been credited to some species. Many Terminalia species have multiple beneficial effects for multiple diseases and ailments. Indeed, the Indian species Terminalia chebula is known as the king of plants in Ayurveda due to its broad range of medicinal uses. However, apart from the reported ethnopharmacological uses of many Terminalia species, surprisingly few studies have rigorously examined this important genus for their medical properties/mechanisms and phytochemistry. This is likely due to the high tannin content common to many Terminalia species and the perception that these tannins may be responsible for much of their beneficial properties. As the complexities of tannins make them poor candidates for drug design, most interest in Terminalia species has been for their pharmacognostic and nutraceutical value and they have often been overlooked as potentials for drug discovery. However, recent reports have identified many other interesting phytochemicals and demonstrated that these may be responsible for several of the reported bioactivities of the Terminalia species used in traditional medicinal systems. The last decade has seen a large increase in the number of studies into the use of Terminalia species as therapeutic agents. Several species used in Ayurvedic medicine (Terminalia arjuna, Terminalia bellerica, Terminalia catappa, T. chebula) in particular have received much recent attention. Similarly, recent reports have also highlighted the medicinal potential of species from Africa, Australia and the Americas. The aim of this report is to summarise the recent research into the medicinal properties, phytochemistry and therapeutic mechanisms of Terminalia species and thus to highlight and direct future areas of research into the medicinal activities of this important genus.

Entities:  

Keywords:  Anticancer; Antimicrobial; Antioxidant; Diabetes; Inflammation; Medicinal plants

Mesh:

Substances:

Year:  2015        PMID: 26226895     DOI: 10.1007/s10787-015-0246-z

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  121 in total

1.  Antioxidant activity of Terminalia arjuna bark extract on N-nitrosodiethylamine induced hepatocellular carcinoma in rats.

Authors:  Sarveswaran Sivalokanathan; Muthaiyan Ilayaraja; Maruthaiveeran Periyasamy Balasubramanian
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

2.  Proteomic analysis of Terminalia chebula extract-dependent changes in human lymphoblastic T cell protein expression.

Authors:  Nando Dulal Das; Kyoung Hwa Jung; Ji Hyun Park; Mi Ran Choi; Hyung Tae Lee; Moo Sung Kim; Sang Rin Lee; Young Gyu Chai
Journal:  J Med Food       Date:  2012-04-03       Impact factor: 2.786

3.  Lymphocyte proliferation in glutathione-depleted lymphocytes: direct relationship between glutathione availability and the proliferative response.

Authors:  D L Hamilos; P Zelarney; J J Mascali
Journal:  Immunopharmacology       Date:  1989 Nov-Dec

4.  Some pharmacological properties of extracts of Terminalia sericea roots.

Authors:  M J Moshi; Z H Mbwambo
Journal:  J Ethnopharmacol       Date:  2004-12-15       Impact factor: 4.360

5.  Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl)benzyl]acetamidine.

Authors:  E Kankuri; K Vaali; R G Knowles; M Lähde; R Korpela; H Vapaatalo; E Moilanen
Journal:  J Pharmacol Exp Ther       Date:  2001-09       Impact factor: 4.030

Review 6.  The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer.

Authors:  E Middleton; C Kandaswami; T C Theoharides
Journal:  Pharmacol Rev       Date:  2000-12       Impact factor: 25.468

7.  Antidiabetic and antioxidant activity of Terminalia belerica. Roxb.

Authors:  M C Sabu; Ramadasan Kuttan
Journal:  Indian J Exp Biol       Date:  2009-04       Impact factor: 0.818

8.  Terminoside A, a new triterpene glycoside from the bark of Terminalia arjuna inhibits nitric oxide production in murine macrophages.

Authors:  Asif Ali; Gurpreet Kaur; Hinna Hamid; Tarique Abdullah; Mohammed Ali; M Niwa; M S Alam
Journal:  J Asian Nat Prod Res       Date:  2003-06       Impact factor: 1.569

9.  Screening of Tanzanian medicinal plants against Plasmodium falciparum and human immunodeficiency virus.

Authors:  Sheila Maregesi; Sabine Van Miert; Christophe Pannecouque; Mohammed H Feiz Haddad; Nina Hermans; Colin W Wright; Arnold J Vlietinck; Sandra Apers; Luc Pieters
Journal:  Planta Med       Date:  2009-08-03       Impact factor: 3.352

Review 10.  The role of oxidant stress and reactive nitrogen species in acetaminophen hepatotoxicity.

Authors:  Hartmut Jaeschke; Tamara R Knight; Mary Lynn Bajt
Journal:  Toxicol Lett       Date:  2003-10-15       Impact factor: 4.372

View more
  22 in total

1.  Hydrolysable tannin-rich fraction from Terminalia chebula Retz. fruits ameliorates collagen-induced arthritis in BALB/c mice.

Authors:  Sanmuga Priya Ekambaram; Senthamil Selvan Perumal; Thamizharasi Erusappan; Aswini Srinivasan
Journal:  Inflammopharmacology       Date:  2019-08-19       Impact factor: 4.473

Review 2.  Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions.

Authors:  Saeid Amini-Nik; Yusef Yousuf; Marc G Jeschke
Journal:  Adv Drug Deliv Rev       Date:  2017-07-27       Impact factor: 15.470

3.  Terminalia chebula Retz. Fruit Extracts Inhibit Bacterial Triggers of Some Autoimmune Diseases and Potentiate the Activity of Tetracycline.

Authors:  Aaron Mandeville; Ian Edwin Cock
Journal:  Indian J Microbiol       Date:  2018-07-12       Impact factor: 2.461

Review 4.  Proanthocyanidins and hydrolysable tannins: occurrence, dietary intake and pharmacological effects.

Authors:  Antonella Smeriglio; Davide Barreca; Ersilia Bellocco; Domenico Trombetta
Journal:  Br J Pharmacol       Date:  2016-10-21       Impact factor: 8.739

5.  Is the pharmaceutical industry's preoccupation with the monotherapy drug model stifling the development of effective new drug therapies?

Authors:  Ian Edwin Cock
Journal:  Inflammopharmacology       Date:  2018-05-07       Impact factor: 4.473

6.  Macro- and microelement content and health risk assessment of heavy metals in various herbs of Iran.

Authors:  Mohammad Moghaddam; Leila Mehdizadeh; Zahra Sharifi
Journal:  Environ Sci Pollut Res Int       Date:  2020-01-28       Impact factor: 4.223

7.  Comparison of the antibacterial activity of Australian Terminalia spp. extracts against Klebsiella pneumoniae: a potential treatment for ankylosing spondylitis.

Authors:  Reece Courtney; Ian Edwin Cock
Journal:  Inflammopharmacology       Date:  2022-01-06       Impact factor: 4.473

8.  Ascorbic acid potentiates the Giardia duodenalis growth inhibitory activity of pure Terminalia ferdinandiana Exell compounds.

Authors:  I E Cock; P Rayan
Journal:  Parasitol Res       Date:  2020-01-06       Impact factor: 2.289

9.  A comparison of the antimicrobial activity and toxicity of six combretum and two terminalia species from southern Africa.

Authors:  I E Cock; S F Van Vuuren
Journal:  Pharmacogn Mag       Date:  2015 Jan-Mar       Impact factor: 1.085

10.  Ancient Food Habits Dictate that Food Can Be Medicine but Medicine Cannot Be "Food"!!

Authors:  Hit Kishore Goswami; Hitendra Kumar Ram
Journal:  Medicines (Basel)       Date:  2017-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.